Qube Research & Technologies (QRT)’s iHuman IH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14	Closed	-$25	–	3683
2024 Q2	$25	Hold	14	–	–	﹤0.01%	3559
2024 Q1	$24	Hold	14	–	–	﹤0.01%	4256
2023 Q4	$43	Hold	14	–	–	﹤0.01%	4080
2023 Q3	$42	Buy	+14	New	+$43	﹤0.01%	3830
2021 Q2	–	Sell	-10,583	Closed	-$132K	–	2511
2021 Q1	$132K	Buy	+10,583	New	+$187K	﹤0.01%	1714

Other funds holding IH

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IH Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of iHuman (IH) in Q3 2024, closing a stake of 14 shares — an estimated $25 sold.

Qube Research & Technologies (QRT) first reported a position in IH in Q1 2021 and held it in 5 quarters. The position peaked at $132K in Q1 2021. 6 funds tracked by Wall St. Rank hold IH as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining iHuman position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 14 iHuman shares in Q3 2024, an estimated $25.
Qube Research & Technologies (QRT) first reported a position in iHuman in Q1 2021 and held it in 5 quarters.
Qube Research & Technologies (QRT)'s iHuman position peaked at $132K in Q1 2021.
6 funds tracked by Wall St. Rank held iHuman as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.